Clinical trials: Hereditary Transthyretin-mediated Amyloidosis With Polyneropathy

Hereditary Transthyretin-mediated Amyloidosis With Polyneropathy, Pregnancy

TEGSEDI Pregnancy Surveillance Program

• Not yet recruiting
• Age: All ages
• Observational study

This is a worldwide safety surveillance study of pregnancy outcomes in women with hATTR-PN who may have been exposed or were not exposed to TEGSEDI prior to or during the pregnancy and of pediatric outcomes up to 1 year of age.

Trial name

NCT04270058

Testing

inotersen

Volunteers

20 people

Sponsor

Akcea Therapeutics